tiprankstipranks
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market

Harmony Biosciences Holdings (HRMY) Financial Statements

Compare
255 Followers

Harmony Biosciences Holdings Financial Overview

Harmony Biosciences Holdings's market cap is currently $1.90B. The company's EPS TTM is $2.51; its P/E ratio is 12.92; Harmony Biosciences Holdings is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $0.63. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 714.73M$ 582.02M$ 437.86M$ 305.44M$ 159.74M
Gross Profit$ 557.92M$ 460.79M$ 354.37M$ 249.92M$ 132.00M
Operating Income$ 190.83M$ 192.03M$ 120.19M$ 68.70M$ 3.68M
EBITDA$ 233.41M$ 221.51M$ 143.57M$ 106.37M$ 1.51M
Net Income$ 145.49M$ 128.85M$ 181.47M$ 34.60M$ -51.86M
Balance Sheet
Cash & Short-Term Investments$ 467.19M$ 353.46M$ 323.12M$ 234.31M$ 228.63M
Total Assets$ 999.20M$ 811.45M$ 673.87M$ 433.44M$ 427.07M
Total Debt$ 16.25M$ 193.57M$ 191.65M$ 191.98M$ 194.25M
Net Debt$ -436.75M$ -118.09M$ -52.14M$ -42.33M$ -34.38M
Total Liabilities$ 340.05M$ 344.46M$ 271.03M$ 246.94M$ 329.89M
Stockholders' Equity$ 659.15M$ 466.99M$ 402.84M$ 186.51M$ 97.18M
Cash Flow
Free Cash Flow$ 218.67M$ 219.07M$ 104.29M$ -1.74M$ -4.99M
Operating Cash Flow$ 219.82M$ 219.39M$ 144.47M$ 98.56M$ -2.98M
Investing Cash Flow$ -67.48M$ -46.44M$ -141.83M$ -100.30M$ -2.00M
Financing Cash Flow$ -11.00M$ -105.55M$ 6.84M$ 7.42M$ 209.16M
Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History

Harmony Biosciences Holdings Debt to Assets

Harmony Biosciences Holdings Cash Flow

Harmony Biosciences Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis